Anticancer agent 355
Anticancer agent 355 is a highly selective and potent anticancer agent, with IC50 values of 64.66 μM and 13.35 μM against HeLa and MDA-MB-231 cancer cells, respectively. Anticancer agent 355 induces plasmid DNA degradation via intercalation or minor groove binding, and disrupts the tertiary structure of BSA by interfering with the interactions of amino acid side chains. Anticancer agent 355 can be used in the research of cervical cancer and breast cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 78831-35-3
- 分子式: C16H12N2O4
- 分子量:296.28
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示
More
生物活性
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | IC50 |
64.66 μM
|
Cytotoxicity against human cervical cancer HeLa cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
Cytotoxicity against human cervical cancer HeLa cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
|
j.inoche.2020.108085 |
| MDA-MB-231 | IC50 |
13.35 μM
|
Cytotoxicity against human breast cancer MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
Cytotoxicity against human breast cancer MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
|
j.inoche.2020.108085 |
| HEK293 | IC50 |
82.75 μM
|
Cytotoxicity against normal human fibroblast HEK-293 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
Cytotoxicity against normal human fibroblast HEK-293 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
|
j.inoche.2020.108085 |
Anticancer agent 355 (Compound S4) (1-3 mg/mL; 1 h) completely degrades plasmid DNA of approximately 1 kb, exhibiting strong chemical nuclease activity[1].
Anticancer agent 355 (9-300 μM; 24 h) exhibits cytotoxicity against HeLa and MDA-MB-231 cancer cells, with IC50 values of 64.66 μM and 13.35 μM, respectively. Meanwhile, compared to normal HEK-293 cells (IC50 = 82.75 μM), this agent shows high selectivity for MDA-MB-231 cells, with a selectivity coefficient of 6.19[1].
Anticancer agent 355 (30 µM) exhibits potent DNA-binding activity via an intercalation mode in in vitro biochemical reactions[1].
Anticancer agent 355 binds to BSA in in vitro biochemical reactions, inducing fluorescence quenching and disruption of the protein's tertiary structure[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 78831-35-3
-
分子量 296.28
-
分子式 C16H12N2O4
-
SMILES
O=C(C1=NC2=C3N=C(C(OC)=O)C=CC3=CC=C2C=C1)OC
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)